Citation Impact
Citing Papers
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
2008 Standout
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Production and isolation of NG2+ oligodendrocyte precursors from human embryonic stem cells in defined serum-free medium
2010
Stroke rehabilitation
2011 Standout
Engineering mammalian cell factories for improved recombinant monoclonal antibody production: lessons from nature?
2005
Hyaluronic Acid Hydrogels for Biomedical Applications
2011 Standout
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
1995 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Accelerated angiogenesis by continuous medium flow with vascular endothelial growth factor inside tissue-engineered trachea☆
2007
Chemoenzymatic Fc Glycosylation via Engineered Aldehyde Tags
2014 StandoutNobel
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
2009 Standout
Embolic strokes of undetermined source: the case for a new clinical construct
2014 Standout
Wound repair and regeneration
2008 StandoutNature
Oral Anticoagulant Therapy
2012 Standout
Pre-Evaluated Safe Human iPSC-Derived Neural Stem Cells Promote Functional Recovery after Spinal Cord Injury in Common Marmoset without Tumorigenicity
2012 StandoutNobel
Antithrombotic Therapy for VTE Disease
2016 Standout
The effect of PEGT/PBT scaffold architecture on oxygen gradients in tissue engineered cartilaginous constructs
2004
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 Standout
Production of recombinant protein therapeutics in cultivated mammalian cells
2004 Standout
Addressing between‐study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non‐rheumatic atrial fibrillation
2009
Antithrombotic Therapy for VTE Disease
2012 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Using exosomes, naturally-equipped nanocarriers, for drug delivery
2015
Executive Summary
2012 Standout
Atrial fibrillation
2011
3D bioprinting of tissues and organs
2014 Standout
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
2012
Self-assembled cellular microarrays patterned using DNA barcodes
2007 StandoutNobel
Toward engineering functional organ modules by additive manufacturing
2012
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
2008 Standout
Capturing complex 3D tissue physiology in vitro
2006 Standout
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
2010 Standout
Cytokinesis-block micronucleus cytome assay
2007 Standout
Porous scaffold design for tissue engineering
2005 Standout
A 3D bioprinting system to produce human-scale tissue constructs with structural integrity
2016 Standout
Micro-bioreactor array for controlling cellular microenvironments
2007
Engineering tissues for in vitro applications
2006
Inclusion of micronuclei in non-divided mononuclear lymphocytes and necrosis/apoptosis may provide a more comprehensive cytokinesis block micronucleus assay for biomonitoring purposes
2001
Variation in Warfarin Thromboprophylaxis After Mitral Valve Repair: Does Equipoise Exist and Is a Randomized Trial Warranted?
2013
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Antithrombotic Therapy for Atrial Fibrillation
2012
Use of regulated secretion in protein production from animal cells: An evaluation with the AtT‐20 model cell line
1990
Antithrombotic Therapy in Atrial Fibrillation
2008
Glycosylation: impact, control and improvement during therapeutic protein production
2013
Effects of Oxygen Transport on 3-D Human Mesenchymal Stem Cell Metabolic Activity in Perfusion and Static Cultures: Experiments and Mathematical Model
2005
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Characterization of chimeric antibody producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressure
1998
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
2007 Standout
Polymers for 3D Printing and Customized Additive Manufacturing
2017 Standout
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Engineering Parameters in Bioreactor’s Design: A Critical Aspect in Tissue Engineering
2013
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation
2014
Progress and Potential for Regenerative Medicine
2006
Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks
2008
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Works of Ralf Pörtner being referenced
A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)
2006
Characterisation of cultivation of the human cell line AGE1.HN.AAT
2011
Regulated overexpression of the survival factor bcl-2 in CHO cells increases viable cell density in batch culture and decreases DNA release in extended fixed-bed cultivation
2000
Bioreactor design for tissue engineering
2005
Perfusion cultures and modelling of oxygen uptake with three-dimensional chondrocyte pellets
1999
Animal Cell Biotechnology
2019
Bioreactor Systems for Tissue Engineering
2009
Cell and Tissue Reaction Engineering
2009